RADIATION PROTECTION IN THE RELEASE OF PATIENTS RECEIVING 131I TREATMENT.

Radiation measurements were made to support radiation protection decisions and instructions concerning the release of patients receiving 131I treatment in Sudan. In hyperthyroidism, administered activity ranged from 370 to 1110 MBq (average: 817.8 MBq), and air-absorbed dose rate at 1 m in front of the patients varied from 20 to 66 µGy h-1 (average: 47.0 µGy h-1). For thyroid cancer patients, the administered activity ranged from 3700 to 7400 MBq (average: 4816.2 MBq), and the air-absorbed dose rate at 1 m in front of the patients ranged from 3 to 55 µSv h-1 (average: 19.2 µSv h-1). On average, the contamination activity was highest in the patients' clothes: 11.0 Bq cm-2, followed by the toilet: 6.6 Bq cm-2 and the front bed: 2.9 Bq cm-2. The estimated release times from the confinement were well with the radiation safety criteria, whereas instruction are given concerning precaution times to limit radiation exposure to family members and co-worker.

RETROSPECTIVE ANALYSIS OF PATIENT RADIATION DOSES IN DIGITAL CORONARY ANGIOGRAPHY AND INTERVENTIONS.

This study sought to assess patient and operator eye lens doses in diagnostic coronary angiography (DCA) and percutaneous coronary interventions (PCI) in a University hospital in Oman. Kerma area product (PkA), cumulative air kerma (CAK) and fluoroscopic time (FT) were retrospectively recorded from the DICOM header for 264 patients. The median (interquartile range) of FT, PKA and CAK were: 5.3 min (2.6-10.5), 60.9 Gy cm2 (41.3-91.4) and 0.86 Gy (0.61-1.29), respectively, for DCA procedures, and they were 20.2 min (13.3-30.1), 174.0 Gy cm2 (113.7-253.3) and 2.6 Gy (1.8-3.9), respectively, for PCI procedures. The results revealed wide variability in patient doses among individual patients. Monitoring and recording patient dose data can be valuable for quality assurance and patient safety purposes. Feedback to the operator may help optimize radiation doses to patients and prompt further action, as needed.

Estimation of effective dose during hystrosalpingography procedures in certain hospitals in Sudan.

The aims of this study were to measure the patients' entrance surface air kerma doses (ESAK), effective doses and to compare practices between different hospitals in Sudan. ESAK were measured for patient using calibrated thermo luminance dosimeters (TLDs, GR200A). Effective doses were estimated using National radiological Protection Board (NRPB) software. This study was conducted in five radiological departments: Two Teaching Hospitals (A and D), two private hospitals (B and C) and one University Hospital (E). The mean ESAK was 20.1mGy, 28.9mGy, 13.6mGy, 17.5mGy, 35.7mGy for hospitals A, B, C, D, and E, respectively. The mean effective dose was 2.4mSv, 3.5mSv, 1.6mSv, 2.1mSv and 4.3mSv in the same order. The study showed wide variations in the ESDs with three of the hospitals having values above the internationally reported values.

Radiation protection in fixed PET/CT facilities--design and operation.

We describe the design of a fixed positron emission tomography (PET)/CT facility and the use of a simulated instantaneous dose-rate plot to visually highlight areas of potentially high radiation exposure. We also illustrate the practical implementation of basic radiation protection principles based on the use of distance and shielding and the minimisation of time spent in hot areas. Staff whole body doses for 4 years are presented with results of an optimisation study analysing the dose arising from the different phases within each study using direct reading dosemeters. The total whole body dose for all staff for each patient fell from 9.5 µSv in the first full year of operation to 4.8 µSv in 2008. The maximum dose to an individual member of staff per patient decreased over the same period from 3.2 to 0.9 µSv. The optimisation study showed that the highest dose was recorded during the injection phase.